388 related articles for article (PubMed ID: 29902710)
21. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY; Jeong JJ; Eun SH; Kim DH
Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages.
Bao S; Zou Y; Wang B; Li Y; Zhu J; Luo Y; Li J
Int Immunopharmacol; 2015 Sep; 28(1):429-34. PubMed ID: 26122136
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
[TBL] [Abstract][Full Text] [Related]
24. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
Front Immunol; 2020; 11():285. PubMed ID: 32158448
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome.
Liu Y; Liu N; Liu Y; He H; Luo Z; Liu W; Song N; Ju M
J Clin Transl Hepatol; 2022 Jun; 10(3):474-485. PubMed ID: 35836757
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment with
Wang X; Han C; Qin J; Wei Y; Qian X; Bao Y; Shi W
J Interferon Cytokine Res; 2019 Aug; 39(8):495-505. PubMed ID: 31074668
[TBL] [Abstract][Full Text] [Related]
27. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
28. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway.
Cheng Z; Li L
Int Immunopharmacol; 2016 May; 34():53-59. PubMed ID: 26921732
[TBL] [Abstract][Full Text] [Related]
30. Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.
Huynh DTN; Baek N; Sim S; Myung CS; Heo KS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932915
[TBL] [Abstract][Full Text] [Related]
31. Beta-sitosterol and its derivatives repress lipopolysaccharide/d-galactosamine-induced acute hepatic injury by inhibiting the oxidation and inflammation in mice.
Yin Y; Liu X; Liu J; Cai E; Zhu H; Li H; Zhang L; Li P; Zhao Y
Bioorg Med Chem Lett; 2018 May; 28(9):1525-1533. PubMed ID: 29622518
[TBL] [Abstract][Full Text] [Related]
32. BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.
Yan D; Liu HL; Yu ZJ; Huang YH; Gao D; Hao H; Liao SS; Xu FY; Zhou XY
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420055
[TBL] [Abstract][Full Text] [Related]
33. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
[TBL] [Abstract][Full Text] [Related]
34. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
35. Diallyl sulfide protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.
Li M; Wang S; Li X; Jiang L; Wang X; Kou R; Wang Q; Xu L; Zhao N; Xie K
Food Chem Toxicol; 2018 Oct; 120():500-509. PubMed ID: 30075314
[TBL] [Abstract][Full Text] [Related]
36. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
[TBL] [Abstract][Full Text] [Related]
37. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
Tang F; Fan K; Wang K; Bian C
Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
[TBL] [Abstract][Full Text] [Related]
38. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury
Jiang MP; Xu C; Guo YW; Luo QJ; Li L; Liu HL; Jiang J; Chen HX; Wei XQ
World J Gastroenterol; 2018 Jan; 24(2):216-225. PubMed ID: 29375207
[TBL] [Abstract][Full Text] [Related]
39. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
Zhu Y; Chen X; Rao X; Zheng C; Peng X
Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
[TBL] [Abstract][Full Text] [Related]
40. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
Lv H; Fan X; Wang L; Feng H; Ci X
Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
